AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2016

Dec 22, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2016-12-22

Reporting Person: Biller Scott (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-22	Common stock	G	7800	$0.00	Disposed	40470	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	6000	Indirect

Footnotes

F1: Represents shares donated by the reporting person to a charitable donor-advised fund.

F2: Shares held by a spousal lifetime access trust, of which the reporting person's wife is trustee.